HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria.

Abstract
We studied gastrointestinal transit in a 57-year-old man with chronic intestinal pseudo-obstruction along with peripheral and autonomic neuropathy due to hereditary coproporphyria and we evaluated the effects of acute and chronic therapy with erythromycin. Noninvasive scintigraphic studies of regional transit of solid residue through the gut were obtained before treatment, during the acute i.v. administration of 500 mg, every-8-h doses of erythromycin for 24 h and after 15 weeks of oral therapy (500 mg, three times daily). During acute i.v. administration, symptoms and transit measurements dramatically improved; however, all parameters and symptoms returned to pretreatment levels during chronic oral therapy. We conclude that hereditary coproporphyria with associated autonomic neuropathy results in significant delay in small bowel and colonic transit; chronic administration of 500 mg three times a day oral erythromycin was not associated with maintenance of the improvement in regional transit and symptoms observed following acute i.v. administration of the drug at the same dose.
AuthorsM J Vassallo, M Camilleri, S N Sullivan, G M Thomforde
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 14 Issue 3 Pg. 255-9 (Apr 1992) ISSN: 0192-0790 [Print] United States
PMID1564302 (Publication Type: Case Reports, Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Coproporphyrins
  • Erythromycin
Topics
  • Administration, Oral
  • Chronic Disease
  • Coproporphyrins (metabolism)
  • Double-Blind Method
  • Erythromycin (administration & dosage, pharmacology)
  • Gastrointestinal Transit (drug effects)
  • Hereditary Sensory and Autonomic Neuropathies (physiopathology)
  • Humans
  • Infusions, Intravenous
  • Intestinal Pseudo-Obstruction (etiology, physiopathology)
  • Liver Diseases (complications, genetics, physiopathology)
  • Male
  • Middle Aged
  • Porphyrias (complications, genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: